75
Views
8
CrossRef citations to date
0
Altmetric
Review

Patient-reported outcomes measurements in epilepsy

, &
Pages 373-384 | Published online: 09 Jan 2014

References

  • Lehrner J, Kalchmayr R, Serles W et al. Health-related quality of life (HRQL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients. Seizure8, 88–92 (1999).
  • Au A, Li P, Chan J et al. Predicting quality of life in Hong Kong Chinese adults with epilepsy. Epilepsy Behav.3, 350–357 (2002).
  • Baker GA. Assessment of quality of life in people with epilepsy: some practical implications. Epilepsia42(Suppl. 3), 66–69 (2001).
  • Johnson EK, Jones JE, Seidenberg M, Hermann BP. The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia45(5), 544–555 (2004).
  • Leidy N, Rentz AM, Grace EM. Evaluating health-related quality of life outcomes in clinical trials of antiepileptic drug therapy. Epilepsia39(9), 965–977 (1998).
  • Rafnusson V, Olafsson E, Hauser WA, Gudmundsson G. Cause specific mortality in adults with unprovoked seizures. A population based incidence cohort study. Neuroepidemiology20(4), 232–236 (2001).
  • US FDA. Guidance for Industry – Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Silver Spring, MD, USA (2006).
  • Committee for Medicinal Products for Human Use (CHMP). Reflection Paper on the Regulatory Guidance for the Use of Health Related Quality of Life (HRQL) Measures in the Evaluation of Medicinal Products. European Medicines Evaluation Authority, London, UK (2006).
  • Owczarek K, Jedrzejczak J, Rozenek H. Cognitive functioning in neuropsychological tests and self-ratings in patients with epilepsy. Acta Neuropsychologica4(1/2), 23–47 (2006).
  • Lee S-A, Yoo H-J, Lee B-I. Factors contributing to the stigma of epilepsy. Seizure14, 157–163 (2005).
  • Panayides S, Goldstein LH, Mouratoglou V, Papacostas S. Patient-validated content of a Greek version of the quality of life in epilepsy inventory (QOLIE-89) combined with individualized measures. Epilepsy Behav.5, 367–379 (2004).
  • Fargo JD, Schefft B, Szaflarski JP et al. Accuracy of self-reported neuropsychological functioning in individuals with epileptic or psychogenic nonepileptic seizures. Epilepsy Behav.5, 143–150 (2004).
  • Berto P. Quality of life in patients with epilepsy and impact of treatments. Pharmacoeconomics20(15), 1039–1059 (2002).
  • Wiebe S, Matijevic S, Eliasziw M, Derry PA. Clinically important change in quality of life in epilepsy. J. Neurol. Neurosurg. Psychiatr.73, 116–120 (2002).
  • Vickerey BH, Berg AT, Sperling MR et al. Relationships between seizure severity and health-related quality of life in refractory localization-related epilepsy. Epilepsia41(6), 760–764 (2000).
  • Leidy N, Elixhauser A, Rentz A et al. Telephone validation of the Quality of Life in Epilepsy Inventory-89 (QOLIE-89). Epilepsia40(1), 97–106 (1999).
  • Leidy NK, Elixhauser A, Vickrey B, Means E, Willian MK. Seizure frequency and the health-related quality of life of adults with epilepsy. Neurology53, 162–166 (1999).
  • Raty L, Hamrin E, Soderfeldt B. Quality of life in newly-debuted epilepsy. An empirical study. Acta Neurol. Scand.100, 221–226 (1999).
  • Breier JI, Fuchs KI, Brookkshire BL et al. Quality of life perceptions in patients with intractable epilepsy or pseudoseizures. Arch. Neurol.55, 660–665 (1998).
  • Grudzinski AN, Hakim Z, Coons SJ, Labiner DM. Use of the QOLIE-31 in routine clinical practice. J. Epilepsy11, 34–47 (1998).
  • Baker GA, Jacoby A, Buck D, Stalgis C, Monnet D. Quality of life of people with epilepsy: a European study. Epilepsia38(3), 353–362 (1997).
  • Wagner AK, Bruce LE, Tran TA, Bungay KM, Cynn DJ, Rogers WH. Patients-based health status measurement in clinical practice: a study of its impact on epilepsy patients’ care. Qual. Life Res.6, 329–341 (1997).
  • Ma KH, Yam KL, Tsui KW, Yau FT. Internal consistency and test-retest reliability of the Chinese version of the self-report health-related quality of life measure for children and adolescents with epilepsy. Epilepsy Behav.9, 51–57 (2006).
  • Yam WKL, Ma DKH, Cherk SWW and the Working Group for Multi-Centre Study on Quality of Life Measures for Youth with Epilepsy. Factor structure and construct validity of the Chinese Health-Related Quality of Life Measure for Youth with Epilepsy. Epilepsy Behav.9, 606–618 (2006).
  • Raty LKA, Larsson BMW, Soderfeldt BA. Health-related quality of life in youth: a comparison between adolescents and young adults with uncomplicated epilepsy and health controls. J. Adolesc. Health33, 252–258 (2003).
  • Ronen GM, Streiner DL, Rosenbaum P; The Canadian Pediatric Network. Health-related quality of life in children with epilepsy: development and validation of self-report and parent proxy measures. Epilepsia44(4), 598–612 (2003).
  • Devinsky O, Westbrook L, Cramer J, Glassman M, Perrine K, Camfield C. Risk factors for poor health-related quality of life in adolescents with epilepsy. Epilepsia40(2), 1715–1720 (1999).
  • Cramer JA, Westbrook LE, Devinsky O, Perrine K, Glassman MB, Camfield C. Development of the Quality of Life in Epilepsy Inventory for Adolescents: the QOLIE-AD-48. Epilepsia40(8), 1114–1121 (1999).
  • Fritz N, Glogau S, Hoffmann J, Rademacher M, Elger CE, Helmstaedter C. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy. Epilepsy Behav.6, 373–381 (2005).
  • Cramer JA, Hammer AE, Kustra RP. Quality of life improvement with conversion to lamotrigine monotherapy. Epilepsy Behav.5, 224–230 (2004).
  • Gunter MJ, Brixner D, Von Worley A, Carter S, Gregory C. Impact of a seizure disorder disease management program on patient-reported quality of life. Dis. Manag.7(6), 333–347 (2004).
  • Vickery BG, Hays RD, Graber J, Rausch R, Engel J Jr, Brook RH. A health-related quality of life instrument for patients evaluated for epilepsy surgery. Med. Care30, 299–319 (1992).
  • Ware JE, Sherbourne CD. The MOS 36-Item Short-Form health Survey. I. Conceptual framework and item selection. Med. Care30(6), 473–483 (1992).
  • Mc Horney CA, Ware JE Jr, Raczek AE. The MOS 36-item Short-Form Health Survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med. Care31(3), 247–263 (1993).
  • Andrews FM, Whithey SB. Social indicators of well-being: Americans’ perception of life quality. Plenum Press, New York, USA (1976).
  • Helmstaedter C, Elger CE. Cognitive-behavioral aspects of quality of life in presurgical patients with epilepsy. J. Epilepsy7, 220–231 (1994).
  • Kendrick AM, Trimble MR. Repertory grid in the assessment of quality of life in patients with epilepsy: the Quality of Life Assessment Schedule. In: Epilepsy and the Quality of Life. Trimble MR, Dodson WE (Eds). Raven Press, NY, USA (1994).
  • Jacoby A, Baker G, Smith D, Dewey M, Chadwick D. Measuring the impact of epilepsy: the development of a novel scale. Epilepsy Research16, 83–88 (1993).
  • Kerns RD, Turk DC, Rudy TE. The West Haven–Yale Multidimensional Pain Inventory (WHYMPI). Pain23, 345–356 (1985).
  • Selai CE, Trimble MR. Adjunctive therapy in epilepsy with new antiepileptic drugs: is it of any value? Seizure7, 417–418 (1998).
  • Selai CE, Trimble MR, Rossor MN, Harvey RJ. Assessing quality of life in dementia: preliminary psychometric testing of the Quality of Life Assessment Schedule (QOLAS). Neuropsychol. Rehabil.11(3/4), 219–243 (2001).
  • Kellett MW, Smith DF, Chadwick DW. Quality of life after epilepsy surgery. J. Neurol. Neurosurg. Psychiatr.63, 52–58 (2007).
  • Selwa LM, Schmidt SL, Malow BA, Beydoun A. Long-term outcome of nonsurgical candidates with medically refractory localization-related epilepsy. Epilepsia44(12), 1568–1572 (2003).
  • Bien CG, Schulze-Bonhage, Soeder BM, Schramm J, Elger CE, Tiemeier H. Assessment of the long-term effects of epilepsy surgery with three different reference groups. Epilepsia47(1), 1865–1869 (2006).
  • Cankurtaran ES, Ulug B, Saygi S, Tiryaki A, Akalan N. Psychiatric morbidity, quality of life and disability in mesial temporal lobe epilepsy patients before and after anterior temporal lobectomy. Epilepsy Behav.7, 116–122 (2005).
  • May TW, Pfafflin M. The efficacy of an educational treatment program for patients with epilepsy (MOSES): results of a controlled randomized study. Epilepsia43(5), 539–549 (2002).
  • Engelberts NHJ, Klein M, Ader H, Heimans JJ, Kastelejin-Nolst DGA, van der Ploeg HM. The effectiveness of cognitive rehabilitation for attention deficits in focal seizures: a randomized controlled study. Epilepsia43(6), 587–595 (2002).
  • Jacoby A. Felt versus enacted stigma: a concept revised. Soc. Sci. Med.38, 269–274 (1994).
  • Antonovsky A. Unraveling the mystery of health: how people manage stress and stay well. Jossey-Bass Publishers, San Francisco, CA, USA (1987).
  • Achenbach TM. Manual for the youth Self Report and 1991 Profile. University of Vermont Department of Psychiatry, Burlingon, VT, USA (1991).
  • Ouvinen-Birgerstam P. ‘I think I am manual’ [Swedish]. Psykologiforlaget, Stockhlom, Sweden (1999).
  • Austin JK, Huberty TJ. Revision of the family-APGAR for use by 8-year-olds. Family Syst. Med.7, 323–327 (1989).
  • Shikiar R, Rentz AM. Satisfaction and medication: an overview of conceptual, methodological, and regulatory issues. Value in Health7(2), 204–216 (2004).
  • Weaver M, Markson PD, Frederick MD, Berger M. Issues in the management of treatment satisfaction. Am. J. Manag. Care3, 579–594 (1997).
  • Marshall GN, Hays RD, Sherbourne CD, Wells KB. The structure of patient satisfaction with outpatient medical care. Psychol. Assess.5(4), 477–483 (1993).
  • Dilorio C, Shafer PO, Letz R, Henry TR, Schomer DL, Yeager K. The association of stigma with self-management and perceptions of healthcare among adults with epilepsy. Epilepsy & Behaviour4, 259–267 (2003).
  • DiIorio C, Shafer PO, Letz R, Henry TR, Schomer DL, Yeager K. Project EASE: a study to test the psychosocial model of epilepsy medication management. Epilepsy Behav.5, 926–936 (2004).
  • Chappell B, Smithson H. Patient views on primary care services for epilepsy ands areas were additional professional knowledge would be welcome. Seizure7, 447–457 (1998).
  • Doughty J, Baker GA, Jacoby A, Lavaud V. Compliance and satisfaction with switching from an immediate-release to sustained-release formulation of valproate in people with epilepsy. Epilepsy Behav.4, 710–716 (2003).
  • Goldstein LH, Minchin L, Stubbs P, Fenwick PBC. Are what people know about their epilepsy and what they want from an epilepsy service related? Seizure6, 435–442 (1997).
  • Jain P, Patterson VH, Morrow JI. What people with epilepsy want from a hospital clinic. Seizure2, 75–78 (1993).
  • Poole K, Moran N, Bell G et al. Patients’ perspectives on services for epilepsy: a survey of patient satisfaction, preferences and information provision in 2394 people with epilepsy. Seizure9, 551–558 (2000).
  • Ryan M, Scott DA, Reeves C et al. Eliciting public preferences for healthcare: a systematic review of techniques. Health Technology Assessment5(5), 1–186 (2001).
  • Bowling A. Research methods in health: investigating health and health services. Open University Press, Buckingham, UK (1997).
  • Hornberger JC, Habraken H, Bloch DA. Minimum data needed on patient preferences for accurate, efficient medical decision making. Med. Care33, 297–310 (1995).
  • Ratcliffe J, Buxton M. Patients’ preferences regarding the process and outcomes of life. Int. J. Technol. Assess. Health Care15, 340–351 (1999).
  • Beusterien K, Dziekan K, Flood E, Harding G, Jordan JC. Understanding patient preferences for HIV medications using adaptive conjoint analysis: feasibility assessment. Value in Health8(4), 453–461 (2005).
  • Wigton RS, Hoellerich VL, Patil KD. How physicians use clinical information in diagnosing pulmonary embolism: an application of conjoint analysis. Med. Decis. Making6, 2–11 (1986).
  • Maas A, Stalpers L. Assessing utilities by means of conjoint measurements: an application in medical decision analysis. Med. Decis. Making12, 288–297 (1992).
  • Verhoef CG, Maas A, Stalpers LJA, Verbeek ALM, Wobbes T, van Daal WAJ. The feasibility of additive conjoint measurement in measuring utilities in breast cancer patients. Health Policy17, 39–50 (1991).
  • Revicki DA, Shakespeare A, Kind P. Preferences for schizophrenia-related health states: a comparison of patients, caregivers, and psychiatrists. Int. Clin. Psychopharamacol.11, 101–108 (1996).
  • Lloyd A, McIntosh E, Price M. The importance of drug adverse effects compared with seizure control for people with epilepsy. Pharmacoeconomics23(11), 1167–1181 (2005).
  • Baker GA, Smith DF, Dewey M, Morrow J, Crawford PM, Chadwick DW. The development of a seizure severity scale as an outcome measure in epilepsy. Epilepsy Res.6, 245–251 (1991).
  • Baker GA, Smith DF, Jacoby A, Hayes JA, Chadwick DW. Liverpool Seizure Severity Scale revisited. Seizure7(3), 201–205 (1998).
  • Matsuura M. Patient satisfaction with polypharmacy reduction in chronic epileptics. Psychiatry Clin. Neurosci.54, 249–253 (2000).
  • Austin J, Dunn D, Huster G, Rose D. Development of scales to measure psychosocial care needs of children with seizures and their parents. J. Neurosci. Nurs.30, 155–160 (1998).
  • Batzel LW, Dodrill CB, Dubinsky BL et al. An objective method for the assessment of psychosocial problems in adolescents with epilepsy. Epilepsia32(2), 202–211 (1991).
  • Curtin LS, Siegal AW. Social functioning in adolescents with epilepsy. Children’s Health Care32(2), 103–114 (2003).
  • Dalrymple J, Appelby J. Cross sectional study of reporting of epileptic seizures to general practitioners. Br. Med. J.320, 94–97 (2000).
  • Dodrill CB, Batzel LW, Queisser HR, Temkin NR. An objective method for the assessment of psychological and social problems among epileptics. Epilepsia21, 123–135 (1980).
  • Jacoby A. Epilepsy and the quality of everyday life; findings from a study of people with well-controlled epilepsy. Soc. Sci. Med.34, 657–666 (1992).
  • Ridsdale L, Robins D, Fitzgerald A, Jeffery S, McGee L. Epilepsy in general practice: patients’ psychological problems and their perception of stigma. Br. J. Gen. Pract.46, 365–366 (1996).
  • Ryan R, Kempner K, Emlen AC. The stigma of epilepsy as a self-concept. Epilepsia21, 433–444 (1980).
  • Wheelcock I, Peterson C, Buchtel HA. Presurgery expectations, postsurgery satisfaction, and psychosocial adjustment after epilepsy surgery. Epilepsia39(5), 487–494 (1998).
  • Brazier J, Ratcliffe J, Salomon J, Tsuchiya A. Measuring and Valuing Health Benefits for Economic Evaluation. Oxford University Press, Oxford, UK (2007).
  • Baker GA, Smith DF, Dewey M, Jacoby A, Chadwick DW. The initial development of a health-related quality of life model as an outcome in epilepsy. Epilepsy Res.16, 25–81 (1993).
  • Turk DC, Dworkin RH, Allen RR et al. Selecting core outcome domains in chronic pain clinical trials: IMMPACT recommendations. Pain106(3), 337–345 (2003).
  • Reeve BB, Hays RD, Bjorner JB et al. Psychometric evaluation and calibration of health-related quality of life item banks: Plans for the patient reported outcome measurement information system (PROMIS), Medical Care45(5 Suppl. 1), S22–S31 (2007).

Website

  • Outcome Measures in Rheumatology (OMERACT) website www.omeract.org

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.